Bubs Australia Ltd
ASX:BUB
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.11
0.17
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BUB stock under the Base Case scenario is 0.16 AUD. Compared to the current market price of 0.12 AUD, Bubs Australia Ltd is Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bubs Australia Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BUB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Bubs Australia Ltd
Balance Sheet Decomposition
Bubs Australia Ltd
Current Assets | 59.6m |
Cash & Short-Term Investments | 17.5m |
Receivables | 9.3m |
Other Current Assets | 32.8m |
Non-Current Assets | 7.1m |
PP&E | 5.4m |
Intangibles | 1.2m |
Other Non-Current Assets | 558.4k |
Current Liabilities | 28.5m |
Accounts Payable | 17.7m |
Short-Term Debt | 5.3m |
Other Current Liabilities | 5.5m |
Non-Current Liabilities | 1.4m |
Long-Term Debt | 986.3k |
Other Non-Current Liabilities | 366.2k |
Earnings Waterfall
Bubs Australia Ltd
Revenue
|
79.7m
AUD
|
Cost of Revenue
|
-41m
AUD
|
Gross Profit
|
38.7m
AUD
|
Operating Expenses
|
-59.6m
AUD
|
Operating Income
|
-20.9m
AUD
|
Other Expenses
|
-133.3k
AUD
|
Net Income
|
-21m
AUD
|
Free Cash Flow Analysis
Bubs Australia Ltd
AUD | |
Free Cash Flow | AUD |
BUB Profitability Score
Profitability Due Diligence
Bubs Australia Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Bubs Australia Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
BUB Solvency Score
Solvency Due Diligence
Bubs Australia Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Bubs Australia Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BUB Price Targets Summary
Bubs Australia Ltd
According to Wall Street analysts, the average 1-year price target for BUB is 0.12 AUD with a low forecast of 0.06 AUD and a high forecast of 0.16 AUD.
Dividends
Current shareholder yield for BUB is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
BUB Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bubs Australia Ltd. is a holding company, which offers organic baby food, goat milk infant formula and fresh dairy products. The company is headquartered in Frenchs Forest, New South Wales and currently employs 35 full-time employees. The firm produces goat dairy products and organic food products for all ages under the Bubs brand. Its products include cow’s milk formula, goats milk formula, organic baby food, cereals, toddler snacks, Vita Bubs, puree, rusks, infant and children's vitamin and mineral supplements. The company also offers children’s vitamin and mineral supplements that are also formulated with goat milk and address immune, bone, digestive and cognitive health concerns parents have for their children. The firm offers goat dairy products and produces goat milk-based formulae for adult everyday use, formulations, and adult immunity support for domestic and export markets. Its products are sold in supermarkets and pharmacies throughout Australia, as well as exported to China, Vietnam, Southeast Asia and the Middle East.
Contact
IPO
Employees
Officers
The intrinsic value of one BUB stock under the Base Case scenario is 0.16 AUD.
Compared to the current market price of 0.12 AUD, Bubs Australia Ltd is Undervalued by 24%.